Current neuropharmacology
Blockade of Interleukin-6 Receptor with Tocilizumab During the Acute Phase of Childhood Immune-Mediated Epilepsy can Lead to a Favorable Outcome - an Observational Study.
Xiaolu Deng, Jielu Tan, Miriam Kessi, Zhanwei Zhang, Fang He, Ciliu Zhang, Fei Yin, Lifen Yang, Jing Peng
Published: 202610.2174/011570159X455475251203194508
Abstract
INTRODUCTION: To explore the role of tocilizumab in treating childhood immune-mediated epilepsy and determine the role of interleukin-6 (IL-6) in its pathogenesis. METHODS: We collected and analyzed clinical information of pediatric patients diagnose…
Preview only. Read the full abstract at the source